HTLV-1 Associated Myelopathy/tropical Spastic Paraparesis - 9 Studies Found

Completed : MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
: Tropical Spastic Paraparesis
: 2002-05-01
Completed : Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
: HTLV-I-Associated Myelopathy
: 2011-04-25
: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da
Completed : Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
: HTLV I Associated Myelopathy
: 2008-10-15
: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to
Completed : Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
: HTLV-1
: 2006-07-12
: Drug: Hu MiK-Beta-1
Terminated : Safety and Efficiency Study of Valproic Acid In HAM/TSP
: HTLV-I-Associated Myelopathy
: 2007-08-20
: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year.
Recruiting : Evaluation of Patients With HAM/TSP
:
  • HTLV-I Infection
  • Tropical Spastic Paraparesis

: 1999-11-03
Completed : Raltegravir for HAM/TSP
: HTLV-I Infection
: 2013-05-21
: Drug: Raltegravir
Terminated : The HAM Infliximab Study
: HTLV-I-associated Myelopathy
: 2009-01-14
: Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti
Completed : Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial
: HTLV-I-associated Myelopathy
: 2006-01-04
: Drug: Zidovudine/lamivudine